Gilead to Pay Merck $200 Million in Damages in Hepatitis C Drug Suit

A federal jury found that Gilead Sciences infringed on two patents held by Merck and its partner Ionis Pharmaceuticals to treat the viral disease.

from WSJ.com: US Business http://ift.tt/1SkqUgy
via IFTTT